Biomarkers are biological measures of a biological state. Our key area of interest is in Pharmocodynamic Biomarkers, which are used to evaluate pharmacological responses and paramount in dose optimisation studies.

They are key tools in personalised medicine allowing for efficient drug efficacy monitoring and aiding in therapeutic-outcome predictions based on different treatment options. By developing an array of pharmacodynamics biomarkers, our treatment decisions will be even more targeted and personalised geared to address the individual patient’s needs.